NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.285

+5.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: donpat	3/28/2006 7:04:57 AM
	of 12873

Vaccine against bird flu Tuesday, 28th March 2006, 07:39 Category: Healthy Living LIFE STYLE EXTRA (UK) - SCIENTISTS have created a vaccine against bird flu using horse antibodies. The Chinese researchers managed to cure mice after infecting them with the killer H5N1 virus. They discovered the antibodies - derived from horses - prevented the animals from dying. The study published in the journal Respiratory Research showed a dose of 1O,OOOth of a gram of the horse anti-serum effectively protected the infected mice. The scientists hope the anti-H5N1 antibodies developed in horses could potentially be used to save dying human bird flu victims or as early treatment for the disease. Dr Jiahai Lu, of Sun Yat-Sen University in Guangzhou, China, and colleagues infected dog kidney cells in the lab with a lethal dose of H5N1 and simultaneously exposed the cells to horse antibodies against H5N1. The cells simultaneously infected with H5N1 and exposed to horse antibodies did not die. The scientists then injected horse antibodies into 40 mice that had been infected with a lethal dose of H5N1 24 hours earlier. They also injected horse serum without H5N1 antibodies into a group of mice that acted as controls. The researchers found 5,OOOth of a gram of antibody protected 70% of the mice against death from bird flu and double the dose protected all the animals. But the mice in the comparison group died nine hours after receiving the normal horse serum that did not contain the H5N1 antibodies. Public health expert Dr Jiahai Lu said: "Until we have an efficacious vaccine, specific anti-H5N1 agents and effective epidemiologic control measures for H5N1 virus infection, highly mpathogenic H5N1 virus is likely to be a major health threat tto the world." He said the vaccine could potentially be used for the early treatment of bird flu patients to reduce the severity of illness and the likelihood of passing on the virus to others. The research had provided "experimental support" for using the vaccine in future large primate or human trials, said Dr Jiahai Lu. Copyright © 2006 National News +44(0)207 684 3000 lse.co.uk

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next